// App-Quantinova.ai

: Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events

Researchers

Presenter

  • M Husain

Principal Investigators

  • S C Bain

  • J F E Mann

  • M Nauck

  • N Poulter

  • F M M Baeres

  • B Goldman

  • A Bloch Thomsen

  • S Marso

Medical Centers

  • Toronto General Hospital/Research Institute (UHN), Toronto, ON, Canada

  • ABMU / Swansea University, Swansea, United Kingdom.

  • Friedrich Alexander University, Erlangen, Germany

  • Ruhr-University Bochum, Bochum, Germany

  • Novo NordiskA/S, Soborg, Denmark

  • HCA Midwest Health Heart & Vascular Institute, Kansas City, United States of America

Locations

  • Canada

  • United Kingdom

  • Germany

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Liraglutide

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved